General Medicine, a nationwide healthcare store, announced on October 6, 2026 that it has raised $120 million in Series B financing. Andreessen Horowitz led the round, with participation from Matrix, VXI Capital, Eli Lilly and Company, Mercy Health through Granger Management, and BoxGroup. The new investment brings the company's total funding to $152 million and reinforces its effort to make healthcare shopping more transparent, accessible, and clinically guided.
Scaling a Consumer-Centered Model
General Medicine was founded in 2023 and launched nationwide in May 2025. The company organizes care around what customers need rather than around medical specialties or institutional structures. Since launch, hundreds of thousands of customers have signed up across the United States, and the company reports an average Net Promoter Score of 80.
A Catalog Built for Comparison
The company's product catalog now includes more than 2,900 products and services across medications, labs, telehealth, specialist e-consults, and select in-person visits and procedures. Customers can search, compare, and purchase care directly, seeing upfront what it costs with and without insurance. General Medicine will use the new capital to expand the store into additional categories of care.
Leadership and Strategic Vision
TJ Parker joined General Medicine full time as Chief Executive Officer in October 2026, while founding CEO Ashwin Muralidharan now serves as Chief Product Officer and Elliot Cohen remains President. Parker said, "Everyone's building a healthcare AI agent that can tell you what you might need." He added that what is missing is the infrastructure that lets people actually act on that guidance.
Addressing Delayed Care
General Medicine reports that 83% of its customers say the company helped them address a health need they had been putting off. One third of those customers had delayed care for more than six months. The average customer health record spans 11 years and is presented to clinicians as a prioritized summary at the time of care.
Executive Quotes on Consumer Needs
Ashwin Muralidharan, Chief Product Officer, said consumers shop by need rather than by specialty. He explained that healthcare has historically been organized around who delivers care, not what someone is trying to accomplish. Elliot Cohen, President, added that when customers can see their options and prices, the rest of the system must compete instead of forcing the customer to navigate a system not built for them.
Investor Perspective
Vineeta Agarwala, General Partner at Andreessen Horowitz, led the investment. She said, "General Medicine has built one of the best patient experiences we've seen in the market." Agarwala cited one-click medical record collection, same-day specialist visits, and prescriptions delivered to the door as evidence that the team has designed a core scaffold for many consumer healthcare products.
Clinical Independence and Pricing Transparency
General Medicine says clinical decisions remain independent, and investor or commercial relationships do not determine which products customers see or which treatments clinicians recommend. The catalog reconciles how customers, clinicians, insurers, laboratories, and health systems may describe the same service differently. That common definition makes pricing, comparison, and clinical matching possible.
The Series B funding round signals growing investor confidence in consumer-centered healthcare infrastructure. General Medicine aims to turn an often fragmented system into a straightforward store where people can compare options, understand costs, and act on clinical guidance. With a national footprint, transparent catalog, and independent clinical model, the company is positioned to influence how Americans access both everyday and specialized care.